Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

Affiliations

• ¹ Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA.
• ² Center for Epigenetics & Disease Prevention, Texas A&M Health, College of Medicine, Houston, TX, USA.
• ³ UA Cancer Center, University of Arizona, Tucson, AZ, USA.
• ⁴ UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, WA, USA.
• ⁵ Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
• ⁶ Department of Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI, USA.
• ⁷ The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
• ⁸ Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
• ⁹ Departments of Medicine and Oncology, McGill University, Montreal, QC, Canada.
• ¹⁰ Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, MD, USA.
• ¹¹ Earle A. Chiles Research Institute, Portland, OR, USA.
• ¹² Department of Pharmacology and Toxicology, College of Pharmacy and UA Cancer Center, University of Arizona, Tucson, AZ, USA.
• ¹³ Center for Cancer Prevention, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX, USA.
• ¹⁴ University of Texas Southwestern Medical Center, Dallas, TX, USA.